New cell therapy tested for Tough-to-Treat cancers
NCT ID NCT07420010
Summary
This is a very early study to first check if a new cell therapy called KT032 is safe and tolerable for people with advanced cancers like ovarian, mesothelioma, or colon cancer. It will involve about 24 adults whose cancer has progressed despite standard treatments. The main goal is to find a safe dose and understand how the body handles the treatment, while also looking for early signs that it might help control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLON CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.